Etoposide, a semi-synthetic compound derived from podophyllotoxin, demonstrates potent antitumor pr…
Introduction Palbociclib, a first-in-class cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor, h…
Introduction In cancer treatment, managing chemotherapy-induced nausea and vomiting (CINV) is cr…
Temozolomide is an oral chemotherapy drug that has revolutionized the treatment of glioblastoma mul…
Sunitinib malate is a multikinase inhibitor that has emerged as a transformative treatment option f…
Nilotinib is a tyrosine kinase inhibitor (TKI) that has revolutionized the treatment of chronic mye…
Lenvatinib, a multikinase inhibitor, has revolutionized the treatment landscape for patients with t…
Background of Ibrutinib Ibrutinib, a small molecule, acts as a potent inhibitor of Burton'…
Introduction: Sickle cell disease (SCD) is a genetic disorder affecting hemoglobin, the protein …
Skin cancer, the most common type worldwide, is on the rise, with melanoma being particularly aggre…
Background Of Crizotinib Crizotinib is a revolutionary approach to treating metastatic non-small…
Metastatic non-small cell lung cancer (NSCLC) is a challenging condition that requires targeted and…
Introduction Alectinib is an oral medication belonging to the second generation of drugs that se…
Introduction: Multiple myeloma, a challenging hematologic cancer marked by abnormal plasma cell …
Introduction: Prostate cancer is a prominent contributor to cancer-related mortality in men glob…